The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
Open accessAbstract
The muscles of IL-6 transgenic mice suffer from atrophy. Experiments were carried out on these transgenic mice to elucidate activation of proteolytic systems in the gastrocnemius muscles and blockage of this activation by treatment with the anti-mouse IL-6 receptor (mIL-6R) antibody. Muscle atrophy observed in 16-wk-old transgenic mice was completely blocked by treatment with the mIL-6R antibody. In association with muscle atrophy, enzymatic activities and mRNA levels of cathepsins (B and L) and mRNA levels of ubiquitins (poly- and mono-ubiquitins) increased, whereas the mRNA level of muscle-specific calpain (calpain 3) decreased. All these changes were completely eliminated by treatment with the mIL-6R antibody. This IL-6 receptor antibody could, therefore, be effective against muscle wasting in sepsis and cancer cachexia, where IL-6 plays an important role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the pilot study of Tsujinaka and colleagues showed that transgenic mice chronically overexpressing IL-6 exhibit a marked muscle atrophy [47]; however, the knockout of IL-6 was not sufficient to prevent sarcopenia in a sepsis mouse model [48].”
From Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting (2023) · cites this paper as [47]
In the citing paper
“However, it has also been shown that proinflammatory cytokines may inhibit muscle progenitor cell differentiation and that the reactive oxygen species that are produced by M1 cells (nitric oxide) can be cytotoxic if present in sufficient quantities, demonstrating the need for resolution of the proinflammatory response for muscle recovery to proceed beyond this initial stage [120–122].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
[41] Cathepsin B, cathepsin H, and cathepsin L
Barrett, A. J., & Kirschke, H. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)80043-2 · Cited by 1,698
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,448
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90368-2 · Cited by 998
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 828
Self-citationEvidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 660
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Mitch, W. E., Medina, R., Grieber, S., May, R. C., England, B. K., Price, S. R., Bailey, J. L., & Goldberg, A. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117208 · Cited by 405
Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ-types
Sorimachi, H., Imajoh‐Ohmi, S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y., & Suzuki, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47225-6 · Cited by 381
Self-citationWing, S. S., & Goldberg, A. L. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.4.e668 · Cited by 345
Interleukin-6 Induces Skeletal Muscle Protein Breakdown in Rats
Goodman, M. N. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43695 · Cited by 303
Matsuda, T., Hirano, T., & Kishimoto, T. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180618 · Cited by 302
Furuno, K., Goodman, M. N., & Goldberg, A. L. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38923-9 · Cited by 295
Medina, R., Wing, S. S., & Goldberg, A. L. (1995) · Biochemical Journal · doi:10.1042/bj3070631 · Cited by 294
Baracos, V., DeVivo, C., Hoyle, D., & Goldberg, A. (1995) · American Journal of Physiology · doi:10.1152/ajpendo.1995.268.5.e996 · Cited by 275
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
Sato, K., Tsuchiya, M., Saldanha, J. W., Koishihara, Y., Ohsugi, Y., Kishimoto, T., & Bendig, M. M. (1993) · PubMed · Cited by 274
Self-citationCytokine receptors and signal transduction
Taga, T., & Kishimoto, T. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1334470 · Cited by 267
Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins
Fong, Y., Moldawer, L. L., Marano, M. A., Wei, H., Barber, A. E., Manogue, K., Tracey, K. J., Kuo, G., Fischman, D. A., Cerami, A., et al. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.3.r659 · Cited by 266
Natural substrates of the Ubiquitin proteolytic pathway
Rechsteiner, M. (1991) · Cell · doi:10.1016/0092-8674(91)90104-7 · Cited by 234
The Acute Metabolic Effects of Tumor Necrosis Factor Administration in Humans
Warren, R. S. (1987) · Archives of Surgery · doi:10.1001/archsurg.1987.01400240042007 · Cited by 233
Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.232 · Cited by 227
Lowell, B. B., Ruderman, N. B., & Goodman, M. N. (1986) · Biochemical Journal · doi:10.1042/bj2340237 · Cited by 222
Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats.
Temparis, S., Asensi, M., Taillandier, D., AUROUSSEAU, E., Larbaud, D., Obled, A., Béchet, D., Ferrara, M., Estrela, J. M., & Attaix, D. (1994) · PubMed · Cited by 214
Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle
Moldawer, L. L., Svaninger, G., Gélin, J., & Lundholm, K. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c766 · Cited by 196
Sorimachi, H., Saido, T. C., & Suzuki, K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80595-4 · Cited by 183
Self-citationDistribution of Cathepsins B and H in Rat Tissues and Peripheral Blood Cells1
Kominami, E., Tsukahara, T., Bando, Y., & Katunuma, N. (1985) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a135277 · Cited by 182
Self-citationSkeletal muscle metabolism in patients with malignant tumor
Lundholm, K., Bylund, A., Holm, J., & Scherstén, T. (1976) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(76)90036-0 · Cited by 180
Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies.
Hirata, Y., Taga, T., Hibi, M., Nakano, N., Hirano, T., & Kishimoto, T. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.9.2900 · Cited by 175
Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family
Dubiel, W., Ferrell, K., Pratt, G., & Rechsteiner, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50002-8 · Cited by 167
Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells.
Kanayama, H., Tanaka, K., Aki, M., Kagawa, S., Miyaji, H., Satoh, M., Okada, F., Sato, S., Shimbara, N., & Ichihara, A. (1991) · PubMed · Cited by 163
Self-citationGarc�a-Mart�nez, C., López-Soriano, F. J., & Argilés, J. M. A. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926829 · Cited by 160
Tsujinaka, T., Ebisui, C., Fujita, J., Kishibuchi, M., Morimoto, T., Ogawa, A., Katsume, A., Ohsugi, Y., Kominami, E., & Monden, M. (1995) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1995.1168 · Cited by 159
Self-citationEbisui, C., Tsujinaka, T., Morimoto, T., Kan, K., Iijima, S., Yano, M., Kominami, E., Tanaka, K., & Monden, M. (1995) · Clinical Science · doi:10.1042/cs0890431 · Cited by 157
Self-citationRegulation of the acute phase and immune responses: interleukin-6.
Sehgal, P. B. (1989) · PubMed · Cited by 148
Tumour necrosis factor‐α increases the ubiquitinization of rat skeletal muscle proteins
Garcia‐Martínez, C., Agell, N., Llovera, M., López-Soriano, F. J., & Argilés, J. M. A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81341-v · Cited by 139
Purification and Tissue Distribution of Rat Cathepsin L1
Bando, Y., Kominami, E., & Katunuma, N. (1986) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a121703 · Cited by 133
Self-citationStrassmann, G., Fong, M., Freter, C. E., Windsor, S., D'Alessandro, F., & Nordan, R. P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116816 · Cited by 131
Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system
Fagan, J. M., Waxman, L., & Goldberg, A. L. (1987) · Biochemical Journal · doi:10.1042/bj2430335 · Cited by 131
Molecular cloning and sequencing of cDNA for rat cathepsin L
Ishidoh, K., Towatari, T., Imajoh, S., Kawasaki, H., Kominami, E., Katunuma, N., & Suzuki, K. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80511-2 · Cited by 114
Self-citationKettelhut, Í. D. C., & Goldberg, A. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113467 · Cited by 110
The Ubiquitin System for Protein Degradation
Hershko, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.61.1.761 · Cited by 97
Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo
Suzuki, H., Yasukawa, K., Saito, T., Goitsuka, R., Hasegawa, A., Ohsugi, Y., Taga, T., & Kishimoto, T. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220806 · Cited by 93
Self-citationJohnson, P. (1990) · International Journal of Biochemistry · doi:10.1016/0020-711x(90)90284-a · Cited by 90
Dubiel, W., Ferrell, K., & Rechsteiner, M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81356-5 · Cited by 84
Tamura, T., Lee, D. H., Osaka, F., Fujiwara, T., Shin, S., Chung, C. H., Tanaka, K., & Ichihara, A. (1991) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(91)90090-9 · Cited by 82
Self-citationUbiquitin Gene Expression in Skeletal Muscle Is Increased by Tumor Necrosis Factor-α
Garcia‐Martínez, C., Llovera, M., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1754 · Cited by 81
Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice
Libert, C., Brouckaert, P., SHAW, A. R., & Fiers, W. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200333 · Cited by 75
Interleukin 6 in Infection and Cancer
Sehgal, P. B. (1990) · Experimental Biology and Medicine · doi:10.3181/00379727-195-43129d · Cited by 71
Purification and characterization of the 26 S proteasome from spinach leaves.
Fujinami, K., Tanahashi, N., Tanaka, K., Ichihara, A., Cejka, Z., Baumeister, W. P., Miyawaki, M., Sato, T., & Nakagawa, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47331-0 · Cited by 58
Self-citation2 Cytokine receptors and signal transduction
Ihle, J. N., Witthuhn, B. A., Tang, B., Yi, T., & Quelle, F. W. (1994) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80005-8 · Cited by 51
Introduction of Human γ1 Immunoglobulin Genes into Fertilized Mouse Eggs1
Yamamura, K., Kikutani, H., Takahashi, N., Taga, T., Akira, S., Kawai, K., Fukuchi, K., Kumahara, Y., Honjo, T., & Kishimoto, T. (1984) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134845 · Cited by 50
Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy.
Kominami, E., Kunio, I., & Katunuma, N. (1987) · PubMed Central · Cited by 40
Self-citationHall-Angerås, M., Hasselgren, P.-O. J., Dimlich, R. V. W., & Fischer, J. E. (1991) · Metabolism · doi:10.1016/0026-0495(91)90114-c · Cited by 35
Human B-Cell Stimulatory Factor-2 Expressed in Escherichia Coli
Asagoe, Y., Yasukawa, K., Saito, T., MARUO, N., Miyata, K., Kono, T., Miyake, T., Kato, T., Kakidani, H., & Mitani, M. (1988) · Nature Biotechnology · doi:10.1038/nbt0788-806 · Cited by 29
Receptor-mediated uptake of horseradish peroxidase in innervated and denervated skeletal muscle
Tågerud, S., & Libelius, R. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90239-3 · Cited by 13
Cited by
Sorted by citations
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,216
Brown, B. N., Ratner, B. D., Goodman, S. B., Amar, S., & Badylak, S. F. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.034 · Cited by 926
Stenvinkel, P., Ketteler, M., Johnson, R. J., Lindholm, B., Pecoits‐Filho, R., RIELLA, M. C., Heimbürger, O., Cederholm, T., & Girndt, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00200.x · Cited by 952
“Moreover, IL-6 receptor antibody has been shown to inhibit muscle atrophy that occurs in IL-6 transgenic mice [70].”
BackgroundC-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
Yeun, J. Y., Levine, R. A., Mantadilok, V., & Kaysen, G. A. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70200-9 · Cited by 885
Interleukin‐6 myokine signaling in skeletal muscle: a double‐edged sword?
Muñoz‐Cánoves, P., Scheele, C., Pedersen, B. K., & Serrano, A. L. (2013) · The FEBS Journal · doi:10.1111/febs.12338 · Cited by 774
Metadata
- Authors
- Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., & Monden, M.
- Affiliations
- Osaka University Hospital (JP)
- The University of Osaka (JP)
- Juntendo University (JP)
- Institute for Quantitative Biosciences, The University of Tokyo (JP)
- Chugai Pharmaceutical Co., Ltd. (Japan) (JP)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-01-01
- Volume
- 97
- Issue
- 1
- Pages
- 244-249
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507086
- OpenAlex
- W2060757943
- Cited by
- 421
- References
- 57
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 10 · 2022: 22 · 2021: 16 · 2020: 13 · 2019: 9 · 2018: 14 · 2017: 11 · 2016: 9 · 2015: 17 · 2014: 9 · 2013: 14 · 2012: 18
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- interleukin-6, IL-6 receptor antibody, muscle atrophy, proteolytic system, cathepsin B, cathepsin L, ubiquitin, CAPN3, gastrocnemius, cancer cachexia, sepsis
- MeSH terms
- Animals, Antibodies, Monoclonal, Body Weight, Calpain, Cathepsin B, Cathepsins, Cysteine Endopeptidases, Humans, Mice, Inbred C57BL, Mice, Transgenic, Multienzyme Complexes, Muscular Atrophy, Organ Size, Endopeptidases, RNA, Messenger, Ubiquitins, Antigens, CD, Interleukin-6, Gene Expression, Rats, Wistar, Receptors, Interleukin, Muscle, Skeletal, Receptors, Interleukin-6, Proteasome Endopeptidase Complex, Mice, Rats, Cathepsin L
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
